Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × veliparib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Glioblastoma 2 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1 Ann Arbor Stage III Non-Hodgkin Lymphoma 1 Advanced Malignant Solid Neoplasm 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma of Lung 1

Interventions

Biopsy 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 4 ruxolitinib 3 X-Rays 3 Cyclophosphamide 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 sodium-iodide symporter 2 duvelisib 2 cemiplimab 2 belinostat 2 Vincristine 2 Prednisone 2 Photons 2 Nivolumab 2 Ipilimumab 2 Immunoglobulin G 2 Etoposide 2 Doxorubicin 2 Disulfides 2 CTLA-4 Antigen 2 Azacitidine 2 talimogene laherparepvec 1 pembrolizumab 1 mogamulizumab 1 enasidenib 1 Whole-Body Irradiation 1 Watchful Waiting 1 Spinal Puncture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡